We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on Product Name Placement in Advertisements
FDA Finalizes Guidance on Product Name Placement in Advertisements
The FDA finalized its guidance on drug advertisements, clarifying the legal requirements for companies in the placement of the product’s name — as well as its size, prominence and frequency in promotional labeling, and the juxtaposition between branded and active ingredient names.